Hayward, CA, Oct. 18, 2023 — In a critical step to improving global healthcare, GenEndeavor secured Phase 2 of the NIH Director’s Transformative Research Award. This grant supports GenEndeavor’s mission to swiftly and effectively detect airborne pathogens.

As the only independent non-academic organization to be honored with the NIH Director's Transformative Research Award, this recognition underscores our groundbreaking work in the field of molecular diagnostics and unwavering commitment to advancing and transforming healthcare solutions.